Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
214 studies found for:    "Ewing sarcoma"
Show Display Options
Rank Status Study
21 Completed Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma
Condition: Non-Metastatic Ewings Sarcoma
Intervention:
22 Completed Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy
Conditions: Ewing's Sarcoma;   Primitive Neuroectodermal Tumor (PNET);   Askin's Tumor of the Chest Wall;   Extraosseous Ewing's Sarcoma (EOE)
Intervention: Drug: Zalypsis
23 Unknown  Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults
Conditions: Ewing Sarcoma;   Osteosarcoma
Intervention: Other: MRI
24 Withdrawn Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
Condition: Ewing's Sarcoma
Intervention: Radiation: External Beam Radiotherapy
25 Recruiting Phase I Study of Olaprib and Temozolomide for Ewings Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: Olaparib;   Drug: Temozolomide
26 Not yet recruiting Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Biological: pbi-shRNA™ EWS/FLI1 Type 1 LPX
27 Terminated
Has Results
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
Conditions: Ewing Sarcoma;   Sarcoma
Intervention: Drug: Mithramycin
28 Completed Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Condition: Ewing's Sarcoma
Intervention: Drug: Olaparib
29 Recruiting Protocol for the Treatment of Metastatic Ewing Sarcoma
Condition: Ewing's Sarcoma (ES)
Interventions: Drug: TEMIRI;   Drug: ADM;   Drug: IFO;   Drug: CYC;   Drug: ETO;   Drug: BUMEL;   Drug: VIN
30 Terminated Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
Conditions: Bone Cancer;   Ewing's Sarcoma
Interventions: Drug: Irinotecan;   Drug: Vincristine;   Drug: Temozolomide;   Drug: Doxorubicin;   Drug: Cytoxan;   Drug: Pegfilgrastim;   Drug: Mesna
31 Completed New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
Conditions: Ewing's Sarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Drug: ADR-529;   Drug: Topotecan;   Drug: G-CSF
32 Active, not recruiting A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
Conditions: Neuroblastoma;   Melanoma;   Osteosarcoma;   Ewing Sarcoma
Intervention: Biological: Anti-GD2 antibody
33 Recruiting ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide or Irinotecan in Patients With Previously Treated, Incurable Ewing Sarcoma
Condition: Ewing Sarcoma
Interventions: Drug: niraparib;   Drug: Temozolomide;   Drug: Irinotecan
34 Completed
Has Results
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Condition: Ewing's Sarcoma Family of Tumors
Intervention: Drug: CP-751,871
35 Completed Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
Condition: Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET)
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
36 Recruiting Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Conditions: Metastatic Ewing Sarcoma;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Bone Marrow;   Metastatic Malignant Neoplasm in the Lung;   Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone;   Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
Interventions: Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Radiation: External Beam Radiation Therapy;   Biological: Ganitumab;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Radiation: Stereotactic Radiosurgery;   Procedure: Therapeutic Surgical Procedure;   Drug: Vincristine Sulfate
37 Completed Study of Tumor Samples From Patients With Ewing Sarcoma
Condition: Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Intervention: Other: laboratory biomarker analysis
38 Recruiting Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Condition: Newly Diagnosed Ewing Sarcoma
Interventions: Drug: Cyclophosphamide;   Device: Doxorubicin;   Drug: Vincristine;   Device: Ifosfamide;   Drug: Etoposide;   Procedure: Surgery;   Radiation: Radiation Therapy*;   Drug: Temozolomide;   Drug: Irinotecan
39 Completed
Has Results
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
Conditions: Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma;   Peripheral Primitive Neuroectodermal Tumor
Interventions: Drug: trabectedin;   Other: pharmacological study
40 Completed Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Conditions: Childhood Chronic Myelogenous Leukemia;   Childhood Desmoplastic Small Round Cell Tumor;   Disseminated Neuroblastoma;   Metastatic Childhood Soft Tissue Sarcoma;   Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Metastatic Osteosarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma
Interventions: Drug: tanespimycin;   Other: pharmacological study;   Other: laboratory biomarker analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years